We focus on developing general platforms for the purification of antibodies, their fragments & proteins in general without the need for any chromatographic steps, specific ligands, membranes or polymers (resins). . Read more
Commercial partner: Ludger Ltd. Anti-TNF therapies, in use for over 20 years in inflammatory bowel disease (IBD) management, continue to be widely regarded as first-line biological therapy in Crohn’s disease. Read more
This project is one of a number that are in competition for funding from the GW4 BioMed2 MRC Doctoral Training Partnership which is offering up to 21 studentships for entry in September 2025. Read more
What most of us do naturally – the breathing 500 million people struggle with as they suffer from incurable lung disease. Epigenetic mechanisms control what genes are switched on or off. Read more
Are you passionate about using cutting-edge computational approaches to tackle complex neurological disorders? Join our dynamic research team at Garvan Institute of Medical Research in Sydney as we embark on an exciting journey to understand Amyotrophic Lateral Sclerosis (ALS) at unprecedented resolution. Read more
This project is one of a number that are in competition for funding from the GW4 BioMed2 MRC Doctoral Training Partnership which is offering up to 21 studentships for entry in September 2025. Read more
The choroid plexus (ChP) is a vital yet understudied brain structure, responsible for secreting cerebrospinal fluid (CSF) and forming the blood-CSF barrier (B-CSF-B). Read more
mTORopathies are a group of rare neurological disorders caused by mutations in the mechanistic target of rapamycin (mTOR) pathway and are associated with malformations of cortical development and intractable epilepsy. Read more
We are thrilled to offer a fully funded 4-year PhD project (including a 3-month industry placement and available to UK and International students) that stands at the cutting edge of epigenetic research, with the potential to transform our understanding of cognitive decline and dementia, particularly Alzheimer’s disease (AD). Read more
Phagocytic cells, such as macrophages and microglia, are crucial for internalising and clearing extracellular targets, including dead cells, lipoproteins, synapses, microorganisms, and protein aggregates. Read more
Immune reactions against pathogens and tumours require several layers of control to safeguard the appropriate management of infectious agents and cancerous… Read more
Parkinson’s disease (PD) is a movement disorder that is now the fastest growing neurological disorder in the world. Despite much research the disease is incurable and there are no treatments that can slow the disease down. Read more
Fixed term contract for 3 years, commencing January 2025. Bursary of £19,237 per annum and a full fee-waiver for UK/International tuition fees. Read more
*Offer only available for the duration of your active subscription, and subject to change. You MUST claim your prize within 72 hours, if not we will redraw.
Do you want hassle-free information and advice?
Create your FindAPhD account and sign up to our newsletter:
Find out about funding opportunities and application tips
Receive weekly advice, student stories and the latest PhD news
Hear about our upcoming study fairs
Save your favourite projects, track enquiries and get personalised subject updates
Due to your Facebook privacy settings, we were unable to create your account at this time. Please select another method to sign up.
We were unable to log you in with your Google account at this time. If you have third-party cookies blocked, please enable them, refresh, and try again.
or
Continue with Facebook
Create your account
We were unable to log you in with your Google account at this time. If you have third-party cookies blocked, please enable them, refresh, and try again.
Looking to list your PhD opportunities? Log in here.